United States · FDA National Drug Code directory

Venclexta

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
0074-0576_5d893369-497c-46ee-9b64-ee737fab4225
Product NDC
0074-0576
Form
TABLET, FILM COATED
Composition / generic term
Venetoclax
Labeler
AbbVie Inc.
Marketing category
NDA
Marketing start / end (source format)
20160411
Source listing expiry
20271231

Source-listed ingredients

  • VENETOCLAX — 100 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 1 BLISTER PACK in 1 CARTON (0074-0576-11) / 1 TABLET, FILM COATED in 1 BLISTER PACK · 0074-0576-11
  • 120 TABLET, FILM COATED in 1 BOTTLE (0074-0576-22) · 0074-0576-22
  • 1 BOTTLE in 1 CARTON (0074-0576-30) / 28 TABLET, FILM COATED in 1 BOTTLE · 0074-0576-30

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →
Venclexta — United States | Molindra Medicines